In late 2011, before the presidential election, the Yu Chang (later TaiMed) Biotech case broke out, involving then-presidential candidate Tsai Ing-wen. As the Vice Premier, Tsai had signed off on a government investment in Yu Chang and later became the chairperson of the company after leaving office. This case exposed a serious "revolving door" and conflict of interest controversy, raising doubts about the ethics of top green camp officials in utilizing national resources to benefit their private enterprises.
‹ 返回事件列表
已結案
The Yu Chang Biotech Scandal: Tsai Ing-wen Involved in Conflict of Interest Controversy Before the General Election
Share Your Perspectives
To preserve a quiet space for deep reflection, we do not host a public comment section. If you have insights on this article, click below to share it to your own social space and start a meaningful conversation with your network.